Effectiveness of switching strategies in CGRP monoclonal antibody therapy for migraine: A retrospective cohort study.
Authors
Jaimes A, Gómez A, Pajares O, Rodríguez-Vico J
Abstract
To evaluate the effectiveness of first switching between monoclonal antibodies (mAbs) targeting calcitonin gene-related peptide (CGRP) or its receptor in the treatment of migraine.
This website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the IASP Privacy Policy. By closing this banner, you agree to the use of cookies.Agree
